Australasian Society of Clinical Immunology and Allergy Ltd

Home - Australasian Society of Clinical Immunology and Allergy (ASCIA)

The peak professional body of clinical immunology and allergy in Australia and New Zealand ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand. ASCIA's purpose is to advance the science and practice of allergy and clinical immunology. This is achieved by promoting the highest standard of medical practice, training, education and research, to improve the quality of life and health of people with immune system disorders. These include allergies, immunodeficiencies and other immune diseases.
45615521452
IČO
NSW 2100
Adresa
allergy.org.au
Web
ascia_news
Twitter (852)
allergyimmunologyspecialists
Facebook (3785)
228541
Návštěvnost
Popis

Australasian Society of Clinical Immunology and Allergy Ltd

Overview

The Australasian Society of Clinical Immunology and Allergy Ltd (ASCIA) is a nonprofit organisation serving as the peak professional body for clinical immunologists and allergy specialists in Australia and New Zealand. ASCIA is a member society of the World Allergy Organisation (WAO) and the Asia Pacific Association of Allergy, Asthma and Clinical Immunology (APAAACI), with affiliations to the Royal Australasian College of Physicians (RACP) as a specialty society[2].

Purpose and Mission

ASCIA's mission is to advance the science and practice of allergy and clinical immunology by promoting education and the highest standards of ethical medical practice. This is achieved through promoting high-quality medical care, education, and research, ultimately improving the health and quality of life of individuals with allergic diseases, immunodeficiencies, and other immune disorders[3][4].

Formation and Structure

ASCIA was formed in 1991 through the merger of the Australian College of Allergy and the Australasian Society of Immunology Clinical Immunology Group. It is headquartered in Brookvale, New South Wales, Australia, and serves the Australasian region[5].

Activities

ASCIA engages in various initiatives to support its mission:

  • Guidelines and Position Statements: ASCIA publishes guidelines and position statements on managing allergy and immune diseases.
  • Education and Training: The society offers online training courses and educational resources to enhance knowledge and skills in the field.
  • Conferences and Meetings: ASCIA hosts the ASCIA Annual Conference and other educational meetings to foster collaboration and innovation.
  • Community Support: ASCIA works closely with community groups to improve awareness and management of allergies and immune diseases[5].

Impact

Through these activities, ASCIA plays a crucial role in setting standards for allergy and immunology care, supporting research, and advocating for the needs of patients with immune disorders in Australia and New Zealand.

[1] https://www.allergy.org.au [2] https://www.healthdirect.gov.au/partners/australasian-society-of-clinical-immunology-and-allergy-ascia [3] https://www.worldallergy.org/component/content/article/australasian-society-of-clinical-immunology-and-allergy-ascia?catid=20&Itemid=101 [4] https://www.acnc.gov.au/charity/charities/74feaaa8-38af-e811-a963-000d3ad24077/profile [5] https://en.wikipedia.org/wiki/Australasian_Society_of_Clinical_Immunology_and_Allergy

Více

Novinky

Poslední komentáře

❤️ So proud to support ASCIA's mission to advance the science of immunology and allergy! Together, we can improve the lives of those affected by immune disorders. 🌟
detail
👏 Exciting updates from ASCIA! Keeping our community informed about new treatments and research is vital. Let’s continue to raise awareness about allergies and immunodeficiencies! 🌍✨
detail

Poslední diskuze

1. How can ASCIA further enhance public awareness and understanding of allergic diseases and immunodeficiencies in the community?
Odpovědí: 3, Naposledy před 1 den detail
2. What are the potential benefits and challenges of implementing the new immunotherapy options, such as ALBEY and ALUSTAL, in clinical practice by April 2025?
Odpovědí: 3, Naposledy před 1 den detail

V okolí

Kontaktovat
Australasian Society of Clinical Immunology and Allergy Ltd logo
Australasian Society of Clinical Immunology and Allergy Ltd
+ Sledovat
4.5
Reviews
NSW 2100
Místo
O společnosti

- D20, E40 -

ASCIA News New international consensus report on anaphylaxis FASENRA benralizumab approved for eosinophilic granulomatosis with polyangiitis EGPA ALBEY venom immunotherapy available from April 2025 ALUSTAL immunotherapy available from April 2025 ASCIA Immunodeficiency Strategy March 2025 update National Allergy Council projectsallocated to ASCIA March 2025 update New ARISE allergic rhinitis hay fever trial Shingrix Vaccine to Prevent Shingles Update ASCIA Member Login ASCIA Update Information for the community about allergic diseases immunodeficiencies and other immune diseases. Join our mailing list or see latest edition here. About ASCIA ASCIA is the peak professional body of clinical immunology and allergy in Australia and NewZealand ASCIA promotes and advances the study and knowledge of allergy and otherimmunediseases Quick Links ASCIA Online Training Immunodeficiency Drug allergy ASCIA welcomes your feedback. About ASCIA ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy.

Ochrana zvířat a welfare (zahrnuje humanitní společnosti a SPCAs) Zařízení pro péči o reproduktivní zdraví a související služby
23 Vacancy More Detail